Mesoblast LimitedASX: MSB

MSB Reports Increased Revenue and Improved Operating Spend

· Issued by Mesoblast Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Mesoblast Limited has reported a significant increase in net revenue and a reduction in operating cash spend for the first fiscal quarter compared to the previous year period, highlighting its strong financial position. The Chief Executive emphasized plans for continued growth and disciplined capital allocation to maximize shareholder value.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/msb-reports-increased-revenue-and-improved-operating-spend

Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call

Release

MESOBLAST REPORTS 44% INCREASE IN RYONCIL® NET REVENUE AND 85% IMPROVEMENT IN NET OPERATING CASH SPEND IN FIRST FISCAL QUARTER OVER PRIOR YEAR PERIOD New York, USA: October 15 and Melbourne, Australia: October 16, 2026: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular...

Mesoblast Limited on 6ix

Story so far

Earlier from Mesoblast

All Mesoblast news releases